Very few prior studies have investigated the presence of ascites as a prognostic factor in children with cirrhosis. To the best of our knowledge, there are no prior studies evaluating the relationship between severity of ascites and patient survival in children with biliary atresia and cirrhosis.Clinically detectable ascites is associated with decreased 1-year survival of children with biliary atresia. These patients should be treated with caution and prioritized for liver transplantation.Background Very few prior studies have investigated the presence of ascites as a prognostic factor in children with cirrhosis. To the best of our knowledge, there are no prior studies evaluating the relationship between severity of ascites and patient su...
BACKGROUND: Acute acalculous cholecystitis (AAC) is generally considered to be a mild disease in chi...
Publisher Copyright: © 2021 The Author(s)Portoenterostomy (PE) has remained as the generally accepte...
We investigated noninvasive follow-up markers for histologic liver fibrosis and portal hypertension ...
Background & Aims: Although ascites is the most frequent first decompensating event in cirrhosis...
PURPOSE: Refractory ascites (RA) is closely related to a high morbidity and mortality. In this study...
Cirrhosis is characterized by the progressive development of portal hypertension. Portal hypertensio...
Background/Aims: The assessment of disease stage in cirrhosis is important for the individual patien...
Objectives: To evaluate the impact of haemorrhagic ascites on prognosis of patients with advance cir...
Ascites represents a critical event in the natural history of liver cirrhosis. From a prognostic per...
Resistant ascites was studied in 34 patients with liver cirrhosis and ascites. The patients were ini...
BACKGROUND/AIMS: One of the prognostic methods for survival in primary biliary cirrhosis (PBC) is th...
ObjectiveBiliary atresia (BA) frequently results in portal hypertension (PHT), complications of whic...
Background: Biliary Atresia (BA) is worldwide the leading cause of end-stage liver disease in childr...
Biliary atresia (BA) is a rare disease of infancy in which obliteration of the biliary tract results...
AbstractAscites formation in patients with cirrhosis, portal hypertension, or both usually results f...
BACKGROUND: Acute acalculous cholecystitis (AAC) is generally considered to be a mild disease in chi...
Publisher Copyright: © 2021 The Author(s)Portoenterostomy (PE) has remained as the generally accepte...
We investigated noninvasive follow-up markers for histologic liver fibrosis and portal hypertension ...
Background & Aims: Although ascites is the most frequent first decompensating event in cirrhosis...
PURPOSE: Refractory ascites (RA) is closely related to a high morbidity and mortality. In this study...
Cirrhosis is characterized by the progressive development of portal hypertension. Portal hypertensio...
Background/Aims: The assessment of disease stage in cirrhosis is important for the individual patien...
Objectives: To evaluate the impact of haemorrhagic ascites on prognosis of patients with advance cir...
Ascites represents a critical event in the natural history of liver cirrhosis. From a prognostic per...
Resistant ascites was studied in 34 patients with liver cirrhosis and ascites. The patients were ini...
BACKGROUND/AIMS: One of the prognostic methods for survival in primary biliary cirrhosis (PBC) is th...
ObjectiveBiliary atresia (BA) frequently results in portal hypertension (PHT), complications of whic...
Background: Biliary Atresia (BA) is worldwide the leading cause of end-stage liver disease in childr...
Biliary atresia (BA) is a rare disease of infancy in which obliteration of the biliary tract results...
AbstractAscites formation in patients with cirrhosis, portal hypertension, or both usually results f...
BACKGROUND: Acute acalculous cholecystitis (AAC) is generally considered to be a mild disease in chi...
Publisher Copyright: © 2021 The Author(s)Portoenterostomy (PE) has remained as the generally accepte...
We investigated noninvasive follow-up markers for histologic liver fibrosis and portal hypertension ...